What about Harbin Pharmaceutical Group People Tongtai Pharmaceutical Co., Ltd.?

Introduction: Sanjing Pharmaceutical Co., Ltd. was established in 1950 with a history of 60 years. At first, it mainly produced muscle and intravenous injection. It is the earliest enterprise specializing in the production of injection in Heilongjiang Province and the first enterprise in China to introduce foreign injection production equipment. From a small pharmaceutical factory with a single dosage form, it has developed into a large group comprehensive pharmaceutical enterprise with multiple varieties and dosage forms, paying equal attention to pharmaceutical raw materials and preparations, and integrating scientific research, production, sales and commerce. Sanjing Pharmaceutical Co., Ltd. covers a total area of 65.438+0.5 million square meters, with total assets of nearly 3 billion yuan and more than 2,000 employees, including more than 600 professional technicians. It is one of the earliest pharmaceutical enterprises that passed the national GMP certification. In 2004 12, the value of intangible assets of Sanjing brand was 4.003 billion yuan, and it won the title of "China Famous Trademark". Up to now, Sanjing Pharmaceutical has 365,438+0 holding and shareholding subsidiaries and seven production bases of oral liquid, freeze-dried powder injection, water injection, tablet production base, external medicine production base, children's medicine production base, Sanjing capsule, chemical raw materials, western medicine powder injection, traditional Chinese medicine extraction production base, granule production base and health care product production base, all of which have entered a stable growth period, providing new ones for further enlargement and strength.

At present, more than 20 dosage forms, 334 varieties and more than 500 specifications have been put into production all over the country and exported to more than 40 countries and regions. The company's oral liquid product workshop has grown into the largest pharmaceutical oral liquid production base in the world, with an annual production capacity of over 65.438+0.7 billion tablets.

Nearly 60 years of pharmaceutical experience, advanced technology and equipment, first-class management methods and perfect research and development system have made the "Sanjing" brand enjoy a high reputation at home and abroad. Sanjing has always regarded products and services as the core competitiveness of the center. At the same time, it attaches great importance to product research and development, invests huge sums of money to establish first-class scientific research buildings at home and abroad, and sets up post-doctoral mobile stations of Harbin Pharmaceutical Group to continuously improve the core competitiveness of enterprises. In recent years, Sanjing Pharmaceutical has successively introduced international standards such as ISO9000, ISO 14000, OHSAS 18000, and obtained certificates. The main products of Sanjing won the honor of "AAA product quality credit rating", and the company has successively won the honorary titles of national advanced quality management enterprise, national contract-abiding enterprise, national excellent pharmaceutical system enterprise, the first batch of innovative pilot enterprises in China, national advanced collective of "May 1 Labor Award", "National Excellent Achievement Award of Corporate Culture" and "China Excellent Integrity Enterprise".

In 2009, Sanjing Pharmaceutical Company achieved an operating income of 2.64 billion yuan and a profit of 360 million yuan.

Legal Representative: Zhang Zhenping

Date of establishment: 1994-02- 19

Registered capital: 579,888,597 yuan.

Location: Heilongjiang Province

Unified social credit code: 91230199128173269w.

Business status: survival (in business, in business, in registration)

Industry: manufacturing industry

Company Type: Other Limited by Share Ltd (listed)

Harbin pharm group sanjing pharmaceutical co., ltd.

Personnel size: private enterprises

Address: No.76, hengshan road, nangang district, Harbin.

Scope: investment management and consulting; Investment and investment management in the medical industry with its own assets; Medical consulting services; Enterprise management consulting; Accept the entrustment and engage in the asset management and enterprise management of the entrusting party.